Find A Physician

Return to Why Choose NewYork-Presbyterian Overview

More on Why Choose NewYork-Presbyterian

Newsroom

Return to Why Choose NewYork-Presbyterian Overview

More on Why Choose NewYork-Presbyterian

Research and Clinical Trials

Return to Why Choose NewYork-Presbyterian Overview

More on Why Choose NewYork-Presbyterian

Clinical Services

Return to Why Choose NewYork-Presbyterian Overview

More on Why Choose NewYork-Presbyterian

Women's Health

Why Choose NewYork-Presbyterian

NewYork-Presbyterian Hospital has a history of discovery and leadership in the prevention and care of gynecologic cancers. This history has led to the comprehensive, collaborative approach that we take today, bringing together all of the specialists needed to provide optimal care for women with gynecologic cancers.

We developed the Pap test:
The Pap test was developed by Dr. George Papanicolaou in the mid-1900s during his tenure at Cornell University Medical College (now Weill Cornell Medical College). Decades later, this test remains the gold standard for screening women for early signs of cervical cancer -- not just in the United States, but around the world.

Minimally invasive surgery:
NewYork-Presbyterian gynecologic oncologists take a minimally invasive approach to cancer surgery whenever possible. Many women are candidates for laparoscopy, which can sometimes be performed as an outpatient procedure and which is associated with smaller incisions, less blood loss, and a shorter recovery time than open abdominal surgery. Some women with endometrial or cervical cancer who require a hysterectomy can have the procedure performed robotically. Both campuses also have a robust robotic surgery program for gynecologic cancer patients.

Fertility preservation programs:
Some approaches to cancer treatment may impair a woman’s fertility. Women of childbearing age who are interested in preserving their fertility may consult with reproductive endocrinology experts at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine at NewYork-Presbyterian/Weill Cornell and The Center for Women's Reproductive Care at Columbia University Medical Center

Embryo freezing and egg freezing options are available to some women before they begin cancer treatment. Gynecologic oncologists can collaborate with infertility specialists to review fertility preservation options for each patient.

Genetic counseling:
Women at risk of ovarian cancer because of a strong family history of the disease may consult with a genetic counselor and undergo genetic testing (for example, screening for BRCA1 and BRCA2 mutations or Lynch syndrome) at NewYork-Presbyterian Hospital. Women who are found to carry such mutations have a number of surgical and non-surgical options available to them to greatly decrease their risk of developing ovarian and fallopian tube cancer.

Access to Breast Centers:
Some women with gynecologic cancers are at increased risk for breast cancer. Patients who receive treatment for gynecologic cancers at NewYork-Presbyterian Hospital have facilitated access to the institution's renowned breast centers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Weill Cornell Breast Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Both centers offer coordinated care for women with or at risk for breast cancer.

Participation in clinical trials:
Both the Herbert Irving Comprehensive Cancer Center and Weill Cornell Cancer Center are members of the Gynecologic Oncology Group (GOG), a nonprofit national organization which promotes excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic cancers. This cooperative clinical trial group coordinates most of the cutting-edge studies in gynecologic cancers and is funded in part by the National Cancer Institute. Many of the therapies used to treat gynecologic cancers today were pioneered and evaluated through clinical trials conducted by the GOG. We also offer industry-sponsored and other clinical trials to patients who are candidates for these studies.

A commitment to education:
Each year, a gynecologic oncology fellow (a doctor who pursues additional training after completing residency) embarks on a combined three-year educational program at both the Weill Cornell and Columbia campuses. This education exposes the trainee to a diverse range of cases and broadens his or her knowledge of gynecologic oncology.

  • Bookmark
  • Print

    Find a Doctor

Click the button above or call
1 877 NYP WELL


eNewsletters
Top of page